Fractures in children with Pompe disease: A potential long-term complication

Pediatric Radiology

Volumn 37, Issue 5, 2007, Pages 437-445

  Case, Laura E ^a   Hanna, Rabi ^a   Frush, Donald P ^a   Krishnamurthy, Vidya ^a   DeArmey, Stephanie ^a   Mackey, Joanne ^a   Boney, Anne ^a   Morgan, Claire ^b   Corzo, Deyanira ^b   Bouchard, Susan ^b   Weber, Thomas J ^a   Chen, Yuan Tsong ^a   Kishnani, Priya S ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b GENZYME CORPORATION   (United States)

Author keywords

Bone density; Children; Fracture; Pompe disease; Radiography; Weight bearing

Indexed keywords

ALPHA GLUCOSIDASE; RECOMBINANT GLUCAN 1,4 ALPHA GLUCOSIDASE; UNCLASSIFIED DRUG;

ARTICLE; BONE RADIOGRAPHY; CASE REPORT; DISEASE COURSE; ENZYME REPLACEMENT; FRACTURE; GLYCOGEN STORAGE DISEASE TYPE 2; HUMAN; INFANT; MALE; ONSET AGE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIOLOGIST; RISK ASSESSMENT; SURVIVAL RATE; WALKING AID;

ALPHA-GLUCOSIDASES; BONE DENSITY; FEMUR; FRACTURES, SPONTANEOUS; GENETIC PREDISPOSITION TO DISEASE; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; HUMERUS; INFANT; MALE; MOTOR ACTIVITY; RISK FACTORS; TIBIA; TIME; WEIGHT-BEARING;

EID: 34147184428     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-007-0428-y     Document Type: Article

References (44)

1. Hirschhorn R, Reuser AJ (2001) Glycogen storage disease type II: Acid alpha-glucosidase (acid maltase) deficiency. In: Scriver AB, Sly W et al (eds) The metabolic and molecular bases of metabolic disease. McGraw Hill, New York, pp 3389-3420
2. Kishnani PS, Howell RR (2004) Pompe disease in infants and children. J Pediatr 144:S35-S43
3. van den Hout HM, Hop W, van Diggelen OP et al (2003) The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics 112:332-340
4. Kishnani PS, Hwu WL, Mandel H et al (2006) A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr 148:671-676
5. Kishnani PS, Steiner RD, Bali D et al (2006) Pompe disease diagnosis and management guideline. Genet Med 8:267-288
6. Amalfitano A, Bengur AR, Morse RP et al (2001) Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trial. Genet Med 3:132-138
7. Klinge L, Straub V, Neudorf U et al (2005) Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: Results of a phase II clinical trial. Neuromuscul Disord 15:24-31
8. van den Hout H, Reuser AJ, Vulto AG et al (2000) Recombinant human alpha-glucosidase from rabbit milk in Pompe patients. Lancet 356:397-398
9. Van den Hout JM, Kamphoven JH, Winkel LP et al (2004) Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. Pediatrics 113:e448-e457
10. Van den Hout JM, Reuser AJ, de Klerk JB et al (2001) Enzyme therapy for Pompe disease with recombinant human alpha-glucosidase from rabbit milk. J Inherit Metab Dis 24:266-274
11. Kishnani PS, Nicolino M, Voit T et al (2006) Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease. J Pediatr 149:89-97
12. Kishnani PS, Corzo D, Nicolino M et al (2007) Recombinant human acid alpha-glucosidase. Major clinical benefits in infantile-onset Pompe disease. Neurology 68:99-109
13. Lewiecki EM, Watts NB, McClung MR et al (2004) Official positions of the international society for clinical densitometry. J Clin Endocrinol Metab 89:3651-3655
14. Bianchi ML, Mazzanti A, Galbiati E et al (2003) Bone mineral density and bone metabolism in Duchenne muscular dystrophy. Osteoporos Int 14:761-767
15. Biggar WD, Bachrach LK, Henderson RC et al (2005) Bone health in Duchenne muscular dystrophy: A workshop report from the meeting in Cincinnati, Ohio, July 8, 2004. Neuromuscul Disord 15:80-85
16. Bothwell JE, Gordon KE, Dooley JM et al (2003) Vertebral fractures in boys with Duchenne muscular dystrophy. Clin Pediatr (Phila) 42:353-356
17. Burke SW, Jameson VP, Roberts JM et al (1986) Birth fractures in spinal muscular atrophy. J Pediatr Orthop 6:34-36
18. Granata C, Giannini S, Villa D et al (1991) Fractures in myopathies. Chir Organi Mov 76:39-45
19. Gray B, Hsu JD, Furumasu J (1992) Fractures caused by falling from a wheelchair in patients with neuromuscular disease. Dev Med Child Neurol 34:589-592
20. Hsu JD (1979) Extremity fractures in children with neuromuscular disease. Johns Hopkins Med J 145:89-93
21. Larson CM, Henderson RC (2000) Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop 20:71-74
22. McDonald DG, Kinali M, Gallagher AC et al (2002) Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol 44:695-698
23. Vestergaard P, Glerup H, Steffensen BF et al (2001) Fracture risk in patients with muscular dystrophy and spinal muscular atrophy. J Rehabil Med 33:150-155
24. Talim B, Malaguti C, Gnudi S et al (2002) Vertebral compression in Duchenne muscular dystrophy following deflazacort. Neuromuscul Disord 12:294-295
25. Germain DP, Benistan K, Boutouyrie P et al (2005) Osteopenia and osteoporosis: Previously unrecognized manifestations of Fabry disease. Clin Genet 68:93-95
26. Pastores GM, Meere PA (2005) Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler-Scheie syndrome (mucopolysaccharidosis type I). Curr Opin Rheumatol 17:70-78
27. Apkon SD (2002) Osteoporosis in children who have disabilities. Phys Med Rehabil Clin N Am 13:839-855
28. Brunner R, Doderlein L (1996) Pathological fractures in patients with cerebral palsy. J Pediatr Orthop B 5:232-238
29. Henderson RC, Lark RK, Gurka MJ et al (2002) Bone density and metabolism in children and adolescents with moderate to severe cerebral palsy. Pediatrics 110(1 Part 1):e5
30. Jiang SD, Dai LY, Jiang LS (2006) Osteoporosis after spinal cord injury. Osteoporos Int 17:180-192
31. Quinlivan R, Roper H, Davie M et al (2005) Report of a Muscular Dystrophy Campaign funded workshop Birmingham, UK, January 16th 2004. Osteoporosis in Duchenne muscular dystrophy; its prevalence, treatment and prevention. Neuromuscul Disord 15:72-79
32. Kinali M, Banks LM, Mercuri E et al (2004) Bone mineral density in a paediatric spinal muscular atrophy population. Neuropediatrics 35:325-328
33. Douvillez B, Braillon P, Hodgkinson I et al (2005) Pain, osteopenia and body composition of 22 patients with Duchenne muscular dystrophy: A descriptive study. Ann Readapt Med Phys 48:616-622
34. Krishnamurthy V, Hanna R, Mackey JM et al (2005) Osteopenia in Pompe disease: A case series presentation. Paper presented at the meeting of the Society of Inherited Metabolic Disorders, Monterey, CA
35. Oktenli C (2000) Renal magnesium wasting, hypomagnesemic hypocalcemia, hypocalciuria and osteopenia in a patient with glycogenosis type II. Am J Nephrol 20:412-417
36. Huang MH, Barrett-Connor E, Greendale GA et al (2006) Hyperkyphotic posture and risk of future osteoporotic fractures: The Rancho Bernardo study. J Bone Miner Res 21:419-423
37. Orchowski J, Polly DW Jr, Klemme WR et al (2000) The effect of kyphosis on the mechanical strength of a long-segment posterior construct using a synthetic model. Spine 25:1644-1648
38. Chad KE, Bailey DA, McKay HA et al (1999) The effect of a weight-bearing physical activity program on bone mineral content and estimated volumetric density in children with spastic cerebral palsy. J Pediatr 135:115-117
39. Goemaere S, Van Laere M, De Neve P et al (1994) Bone mineral status in paraplegic patients who do or do not perform standing. Osteoporos Int 4:138-143
40. Gudjonsdottir B, Mercer VS (2002) Effects of a dynamic versus a static prone stander on bone mineral density and behavior in four children with severe cerebral palsy. Pediatr Phys Ther 14:38-46
41. Ward K, Alsop C, Caulton J et al (2004) Low magnitude mechanical loading is osteogenic in children with disabling conditions. J Bone Miner Res 19:360-369
42. Bianchi ML (2005) How to manage osteoporosis in children. Best Pract Res Clin Rheumatol 19:991-1005
43. Hawker GA, Ridout R, Harris VA et al (2005) Alendronate in the treatment of low bone mass in steroid-treated boys with Duchennes muscular dystrophy. Arch Phys Med Rehabil 86:284-288
44. Wagner KR, Lechtzin N, Judge DP (2007) Current treatment of adult Duchenne muscular dystrophy. Biochim Biophys Acta 1772:229-237